pharma competition

CagriSema Falls Short as Lilly’s Retatrutide Sets New Efficacy Bar

Novo Nordisk's CagriSema Falls Short Against Lilly's Retatrutide as Potent Efficacy Redefines Market Battle In the escalating race for dominance in the multi-billion...

FreshBasket1 Mins read